NeuroOne Medical Technologies Corporation Share Price
Equities
NMTC
US64130M2098
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.13 USD | +1.80% | -1.74% | -28.48% |
Sales 2022 | 2.12 169.75 | Sales 2023 | 3.41 272.85 | Capitalization | 21.3M 1.71B |
---|---|---|---|---|---|
Net income 2022 | -10M -801M | Net income 2023 | -11M -881M | EV / Sales 2022 | 7,761,717 x |
Net cash position 2022 | 10.94M 876M | Net cash position 2023 | 5.14M 411M | EV / Sales 2023 | 4,742,168 x |
P/E ratio 2022 |
-2.7
x | P/E ratio 2023 |
-1.36
x | Employees | 16 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.9% |
Latest transcript on NeuroOne Medical Technologies Corporation
1 day | +1.80% | ||
1 week | -1.74% | ||
Current month | -5.83% | ||
1 month | -6.22% | ||
3 months | -9.24% | ||
6 months | +15.91% | ||
Current year | -28.48% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Christanson
FOU | Founder | 56 | 19/08/09 |
David Rosa
CEO | Chief Executive Officer | 59 | 19/07/17 |
Ronald McClurg
DFI | Director of Finance/CFO | 65 | 31/12/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Buckman
CHM | Chairman | 68 | 03/08/17 |
Director/Board Member | 63 | 03/08/17 | |
Edward Andrle
BRD | Director/Board Member | 66 | 17/02/20 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.13 | +1.80% | 59,275 |
25/04/24 | 1.11 | -4.31% | 38,572 |
24/04/24 | 1.16 | +1.75% | 525,154 |
23/04/24 | 1.14 | 0.00% | 52,236 |
22/04/24 | 1.14 | -0.87% | 72,192 |
Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-28.48% | 29.3M | |
-12.91% | 19.08B | |
-46.21% | 2.65B | |
+18.15% | 1.87B | |
-3.12% | 1.61B | |
+23.78% | 1.21B | |
-10.69% | 1.02B | |
-20.89% | 905M | |
-7.14% | 716M | |
-18.10% | 682M |
- Stock Market
- Equities
- NMTC Stock